Wall Street Is Counting Out The Biggest Breakthrough In Medicine – Here’s How To Make Their Mistake Into Your Gain

When Wall Street overreacts and goes right, you can make a fortune by avoiding the noise and going in the opposite direction.

In the latest edition of wild overreactions, Cathie Wood, the top-notch ETF manager of Ark Investment Management, received some flak from The Wall Street Journal.

I’ll have more on that in just a bit and why it is totally off the mark.

But make no mistake. Wood has an uncanny eye for finding breakout stocks with a market-beating track record to prove it.

One particular feather in Wood’s cap is an ETF that she runs focusing on the cutting-edge field of genomics, a tech that basically didn’t exist just a decade ago.

Without genomics, we wouldn’t have been able to understand the structure of the coronavirus. Not only that, but the first two vaccines approved both relied on a hot new segment of genomics.

And this is an industry that is projected to multiply from $18.85 billion in 2019 to $82.60 billion in 2027, according to Fortune Business Insights. That’s more than 300% growth in less than a decade.

I’ll give you more details in a moment. But first, I want to point out the sizzling returns that Wood has amassed.

Over roughly the past year, Wood’s fund beat the market by a stunning 471%.

Stock, Trading, Monitor, Business

Image source: Pixabay

Let me show you why this play is just getting started…

The Medicine Revolution

To be clear, the Journal story was looking at all five ARK funds that Wood runs.

Fair enough. During the recent tech correction, they significantly underperformed the Nasdaq.

But that brings me to a point you and I have been talking about for years now – it pays to take the long view and look at corrections as great buying opportunities.

It’s pretty true across the public markets, and the genomics play I’m about to tell you about is no exception. Now, there’s another way to beat Wall Street’s hype when it comes to corrections, and that’s to go into private markets, where the pressures of the shifting stock-market don’t apply.

1 2 3 4
View single page >> |

Disclosure: None.

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.